Shuhong Ye
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Quercetin-loaded cellulose nanocrystals for targeted redox modulation and inflammation control in rosacea therapy via the SOD2-NF-κB pathway.
Journal: International journal of biological macromolecules
Published: September 20, 2025
Optimized combination: Isotretinoin in conjunction with oral tranexamic acid for the treatment of moderate to severe acne vulgaris-A randomized, double-blind, placebo-controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: June 16, 2025
Response to Comments on "Oral Tranexamic Acid Treats Papulopustular Rosacea by Improving the Skin Barrier".
Journal: Journal of cosmetic dermatology
Published: January 03, 2025
Efficacy and Safety of Topical Compound Heparin Sodium Allantoin Gel (Main Components: Onion Extract Quercetin) for the Treatment of Rosacea.
Journal: Journal of cosmetic dermatology
Published: December 22, 2024
DNAJB2 Attenuates Rosacea Skin Inflammation and Angiogenesis by Inhibiting the Endoplasmic Reticulum Stress-mediated TLR2/Myd88/NF-κB pathway.
Journal: Inflammation
Published: November 19, 2024
Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study.
Journal: Journal of the American Academy of Dermatology
Published: July 09, 2024
Investigation and Confirmation of PYCARD as a Potential Biomarker for the Management of Psoriasis Disease.
Journal: Journal of inflammation research
Published: May 21, 2024
Oral tranexamic acid treats papulopustular rosacea by improving the skin barrier.
Journal: Journal of cosmetic dermatology
Published: January 09, 2024
Effect of the JAK1 Inhibitor, Upadacitinib, on Skin Barrier Repair of Eczema Elicited During Anti-Interleukin-17 Treatment for Psoriasis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: December 29, 2023
Treatment of refractory psoriasis with dermatomyositis using upadacitinib.
Journal: Clinical and experimental rheumatology
Published: July 14, 2023
JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series.
Journal: Frontiers in medicine
Published: June 14, 2023
A study of the efficacy and safety of plaque psoriasis treatment by TNF-α and IL-17A inhibitor biologics in patients who received the inactivated SARS-CoV-2 vaccine.
Journal: Immunity, inflammation and disease
Published: January 17, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026